Sebelipase Alfa: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sebelipase Alfa. Educational only — not medical advice.
Labeled uses
KANUMA® is indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency.
Source: FDA labeling via NIH DailyMed (set 83a77b9d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.